Literature DB >> 20498404

Defective mismatch repair in colon cancer: a prognostic or predictive biomarker?

David J Kerr, Rachel Midgley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20498404     DOI： 10.1200/JCO.2010.28.9322

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  13 in total

1.  Biological markers: Tailoring treatment and trials to prognosis.

Authors:  David J Kerr; Yuankai Shi
Journal:  Nat Rev Clin Oncol       Date:  2013-06-11       Impact factor: 66.675

Review 2.  Mitotic crossover--an evolutionary rudiment which promotes carcinogenesis of colorectal carcinoma.

Authors:  Branislav Rovcanin; Ivan Ivanovski; Olivera Djuric; Dimitrije Nikolic; Jelena Petrovic; Petar Ivanovski
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

Review 3.  Prognostic and predictive significance of MSI in stages II/III colon cancer.

Authors:  Zacharenia Saridaki; John Souglakos; Vassilis Georgoulias
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

Review 4.  Persistence of DNA adducts, hypermutation and acquisition of cellular resistance to alkylating agents in glioblastoma.

Authors:  R J Head; M F Fay; L Cosgrove; K Y C Fung; D Rundle-Thiele; J H Martin
Journal:  Cancer Biol Ther       Date:  2017-11-20       Impact factor: 4.742

5.  Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer.

Authors:  P Kelly; F Paulin; D Lamont; L Baker; S Clearly; D Exon; A Thompson
Journal:  Br J Cancer       Date:  2012-01-31       Impact factor: 7.640

6.  Review of histopathological and molecular prognostic features in colorectal cancer.

Authors:  Ola Marzouk; John Schofield
Journal:  Cancers (Basel)       Date:  2011-06-23       Impact factor: 6.639

7.  Chromatin organisation and cancer prognosis: a pan-cancer study.

Authors:  Andreas Kleppe; Fritz Albregtsen; Ljiljana Vlatkovic; Manohar Pradhan; Birgitte Nielsen; Tarjei S Hveem; Hanne A Askautrud; Gunnar B Kristensen; Arild Nesbakken; Jone Trovik; Håkon Wæhre; Ian Tomlinson; Neil A Shepherd; Marco Novelli; David J Kerr; Håvard E Danielsen
Journal:  Lancet Oncol       Date:  2018-02-03       Impact factor: 54.433

8.  Radiotherapy response in microsatellite instability related rectal cancer.

Authors:  Joo-Shik Shin; Thein Ga Tut; Tao Yang; C Soon Lee
Journal:  Korean J Pathol       Date:  2013-02-25

9.  Ribonucleotide reductase small subunit M2 serves as a prognostic biomarker and predicts poor survival of colorectal cancers.

Authors:  Xiyong Liu; Hang Zhang; Lily Lai; Xiaochen Wang; Sofia Loera; Lijun Xue; Huiyin He; Keqiang Zhang; Shuya Hu; Yasheng Huang; Rebecca A Nelson; Bingsen Zhou; Lun Zhou; Peiguo Chu; Suzhan Zhang; Shu Zheng; Yun Yen
Journal:  Clin Sci (Lond)       Date:  2013-05       Impact factor: 6.124

10.  Identification of colorectal cancers with defective DNA damage repair by immunohistochemical profiling of mismatch repair proteins, CDX2 and BRCA1.

Authors:  Savitha Rajarajan; Anupama C E; Betsy Jose; Marjorie Correa; Sagar Sengupta; Jyothi S Prabhu
Journal:  Mol Clin Oncol       Date:  2020-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.